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INTRODUCTION 
The anemia is called into the state of 
decrease in counts size of Red Blood Cells and 
Hemoglobin, so that the transfer of O2 and CO2 
is been defeated.
1,2
 
Anemia is one of the most important 
diseases related to poor nutrition, and one of the 
most serious health jeopardy in the over age 
people, but the most prevalence is reported for 
5 years old children and pregnant women. 
According to WHO statistics, 2 billion persons 
(25% of population of the world) suffer from 
anemia that the pregnant women are 
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ABSTRACT 
Background and aims: The prevalence of iron deficiency anemia (IDA) in pregnant 
women is in Variable between 40-80% in developing countries. There are some 
differences among different studies on this disorder. So, this present study is been 
performed for evaluating the prevalence of IDA among pregnant Iranians with systematic 
review and meta-analysis method. 
Methods: This study is based on received information achieved from Magiran, 
Iranmedex, SID, Med Lib, Iran Doc, Scopus, Pubmed, Science Direct, Cochrane, 
Embase, Medline, Springer, Online Library Wiley and Google Scholar in chronological 
order of 1 January 1991 to 31 march 2015 with using standard key words. Search and 
extraction of data were done by two independent reviewers. Using random effects model 
and meta-analysis, the data were analyzed through SPSS. 
Results: In the 32 eligible studies, the 63372 individuals have been evaluated. The 
prevalence of anemia among pregnant Iranians was estimated to be 14.2% (95%  
CI: 12-16.3%). Most prevalence of anemia was seen in the study, the samples of which 
were collected in several parts of country, (21.5%) and the lowest prevalence was seen in 
the West of the country (7%). The prevalence of anemia in urban and rural pregnant 
women was estimated 13.7% and 20% approximately, respectively. 
Conclusion: The prevalence of anemia among pregnant Iranians in the recent 24 years 
according to WHO system reported to be low in developing countries, that it was related 
to appropriate planning and caring in pregnancy period in countries. 
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responsible of 56 million. In this statistic, the 
half of anemia included iron deficiency anemia 
(IDA) (with ICD code 280.9). The prevalence 
of that in the developing countries is 35-100%. 
As the performed studied, the anemia is 
responsible for 15-20% of pregnant mothers’ 
death.
2-7
 
Despite IDA hasn`t any effect on neonate's 
haemoglobin, it can cause some problems such 
as early fatigue, vertigo, pre-term birth, vaginal 
growth disorder, neonate`s anomalies, low 
weight and death of neonates.
8-11
 
The requirement of iron augments in 
pregnant period leads into IDA due to 
inappropriate diet and lack of supplementary 
iron. The cut-off point haemoglobin reported 
by WHO for anemia was less than 11 mg/dl 
and in order to confirm the Academy of 
Nutrition and Pregnancy, it is less than  
11 mg/dl in first and third trimester and less 
than 10.5 mg/dl in second trimester, So that the 
every amount less than 10.5 mg/dl is been 
considered as anemia.
12,13
 
The systematic review performed by 
Esmat Baruti; 2005 in Iran was done among 
11037 samples, and the minimum and 
maximum were reported as 4.3 and 21.5% 
among pregnant women, respectively, and the 
cumulative prevalence of anemia disorder 
among pregnant women was estimated 
13.6(95% CI: 8.3-19.0) according to WHO 
(less than 11mgr/dl) standards.
14
 
There are several studies that they 
reported different prevalence on anemia 
among pregnant women (16-47). One of the 
purposes of meta-analysis studies that 
included several studies is decreasing the 
different of parameters corroborating increase 
the numerous of studies. The other important 
purpose of this kind is to grasp congruous 
between parameters and reason of them. In 
the present study tried by using structured 
review method and meta-analysis, we 
achieved the estimation of the prevalence of 
anemia among pregnant Iranians. 
METHODS 
This study is a regular review and 
systematic one. The results are according to 
published articles in Iranian and foreign 
Journals. In order to achieve Persian and Latin 
documentaries, the websites such as Magiran, 
Iranmedex, SID, Med Lib, Iran Doc, Scopus, 
PubMed, science Direct, Cochrane, Embase, 
Medline, Springer, Online Library Wiley and 
Google Scholar in the chronological order 1 
January 1991 to 31 march 2015 by using 
standard key words were searched. The 
keywords included prevalence, anemia, 
haemoglobin, Ferritin, pregnancy, the pregnant 
period cares and combining them and Persian 
equivalent for Iranian websites. The quality of 
the studies was evaluated on their performance 
and studding method, so the STORBE check 
list was used including 22 parts related to 
certain studies.
15
 
The inclusion standards considered as the 
prevalence of anemia among pregnant Iranians 
according to WHO standards (HB less than  
11 mg/dl) in Persian and English languages in 
1991-2015. All of the studies which had 
mistaken in choosing the sample amount and 
irrelevancy issue were ruled out. In the next 
step, the reviewer evaluated the different aspect 
of methodology like sampling methods, 
measuring varieties, statically analysing and 
purposes of study by using STORBE check list 
including 22 parts. In this check list, the lowest 
achieved score was 15.5 to analysed studies 
and their data were collected for meta-analysis 
process. Every disagreement in beliefs of  
2 reviewers was analysed by third reviewers. 
To thwart of bias, the search was done by  
2 independent researchers and the repeated 
studies were omitted, so the 580 related studies 
were found about anemia of pregnant Iranians. 
The 350 studies were omitted because of 
repeated and unrelated. From 230 last studies, 
the 199 were omitted by reading full-text and 
being unrelated and not having entrance 
criterions (Figure 1). 
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Figure 1: The entrance steps of systematic review and meta-analysis 
 
All of the appropriated inclusion studies 
were prepared to extract by using  
past-prepared check list. The check list 
included authors, year, location, type of study, 
samples volume, mean age, pregnancy age, 
HB cut-off point, the prevalence of anemia, 
Ferritin cut-off point, the prevalence of IDA, 
the prevalence of lacking of Iron and rural or 
urban sample volume. 
Statically analysis 
The prevalence of anemia was considered 
as binomial distribution in every study, and its 
variance was calculated. The incongruous of 
studies was calculated through Q test and 
I2 index. According to incongruous, it was 
used as the random effect model for 
combining the results of studies. The data 
were analysed by Stata Ver.11.1 software. 
The p-value of tests was considered as 
0.05. 
 
RESULTS 
In the systematic review of initial 
studies, the 580 studies were elicited, and 
the 130 related studies were detected with 
review of titles and abstracts, and the  
31 studies were meta-analysis with 63372 
volume samples and 25.6 years old mean 
age (95% CI: 21.99-29.21). In this 
number, the 6 studies were performed in 
West (19.3%), the 10 in Centre (32.3%), 
the 7 in South (22.6%), the 6 in North 
(19.3%), the 1 in East (3.2%), and one of 
them (3.2%) was performed in several 
sections of countries (Table 1). 
 
The 350 repeated studies 
were omitted 
 
Check titles 
The 230 studies were 
evaluated 
 The 100 studies were 
omitted because of being 
repeated 
 
 
The full-text of 130 
studies were achieved 
 
The 99 studies were 
omitted 
  
Check Full Text 
Finally the 31 studies 
with good quality were 
achieved 
The 580 articles were 
collected through search 
 
Check Abstract 
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Table 1: Detailed characteristics of 32 articles included in the systematic review on the 
prevalence of anemia during pregnancy in Iran 
Author Place of 
study 
(source) 
Sample 
size 
Place Year Gestational age 
(Week) 
Hb cut-off 
Point (gr/d) 
Prevalence 
of anemia 
Ferritin 
cut-off 
point for 
IDA (ng/dl) 
Prevalence 
of iron 
deficiency 
Ranaei
16
 Sanandaj 1137 Urban 2009  11 8   
Sadeghian
17
 Tabas 34 Rural 2010  11 5.9   
Mirzaie
18
 Kerman 2213  2005 First and second 
and third trimester 
11 4.7   
Sharifi
19
 Shiraz 400 Both 2011  11 12.3   
Soofizadeh
20
 Sanandaj 1500 Urban 2009 First trimester 11 7.1   
Mostaajeran
21
 Isfahan 7233 Both 2010   9.4   
Alizadeh
22
 Ardabil 312  2011 third trimester 11 23.2   
Vaghari
23
 Gorgan 48 Urban 2007  11 25.8  35.6 
Rahbar
24
 Semnan 546  2010 First trimester  32.1 25  
Akbarzadeh
25
 Shiraz 89 Rural 2009 First and second 
and third trimester 
10.5 29.2   
Pasdar
26
 Kermanshah 32450  2010 First and second 
and third trimester 
11 3.6   
Riahinejad
27
 Isfahan 280 Urban 2012 third trimester 11 4.6   
Farji
28
 Rasht 555 Urban 2008 First trimester 11 21.3 12  
Yazdani
29
 Shiraz 2000 Urban 2002  11 9   
Asnafi
30
 Babol 214  2000 First and second 
and third trimester 
10.5 9.4   
Khademi31 Bandar-abbas 401 Both 2001 First and second 
and third trimester 
10.5 17.5   
Jalali
32
 Eslam-shahr 266 Urban 2004 First and second 
and third trimester 
11 10.2 10 37.3 
Navidian
33
 Zahedan 287 Urban 2003 third trimester 11 12.9   
Safavi34 Several regions of Iran 4368 Both 2001 second and third 
trimester 
10.5 21.5 12 42.2 
Kalantari
35
 Isfahan 799 Urban 1999 Second trimester 11 14.2 12 42.7 
Ghasemzadeh
36
 Tehran 308 Urban 2004  11  15 50.9 
Rahbar
37
 Semnan 691 Urban 1999 third trimester  16.9   
Yarahmadi
38
 Kermanshah 326  1999   17.2   
Lotfizadeh
39
 Tehran 417  1995  11 17.5 12  
Soheilizadeh
40
 Varamin 251  1993   26.1  34.8 
Salarilak
41
 Orumie 400 Urban 1998  11 4.3   
Hajian
42
 Babol 871  2004  11 6.4  13.8 
Borna
43
 Tehran 970 Urban 2002 third trimester 10.5 14.9   
Davaritanha
44
 Tehran 302 Urban 2003 First and second 
and third trimester 
11 8.6   
Karimi
45
 Shiraz 263 Urban 1999 Second trimester  16.7   
Fararooei
46
 Fars province 3371 Both 1996  11 4.1  28.5 
Vahidinia
47
 Hamedan 378 Urban 2000  11 4.8   
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The prevalence of anemia among 
pregnant Iranians according to WHO 
reports is estimated to be 14.2% (95% CI: 
12-16.3). The lowest and the most reported 
prevalence of anemia in existence studies 
is related to Kermanshah; 2010 (4.1%) and 
Isfahan; 2012 (46%) (Figure 2). 
The prevalence of anemia among 
pregnant Iranians was collected in chart 2 
in order to geographic differential, so the 
most prevalence of anemia was seen in the 
study, which it is used the samples 
collected in several parts of country, 
(21.5%) and the lowest prevalence was 
seen in the West of country (Figure 3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: The prevalence of anemia according to WHO definition (HB less than 11mg/dl) 
In Iranians pregnant and based on random effect model, and mean point of each segment showed the estimation of 
percent and the length of each segment showed the 95% confidential interval in each study. The mark diamond 
showed the prevalence of each study. 
NOTE: Weights are from random effects analysis
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Figure 3: The prevalence of Anemia among Iranians pregnant based on geographic 
differentiated according to WHO definition (HB less than 11 mg/dl) 
Based on random effect model, and mean point of each segment showed the estimation of percent and the length of each 
segment showed the 95% confidential interval in each study. The mark diamond showed the prevalence of each study. 
 
NOTE: Weights are from random effects analysis
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The prevalence of anemia in urban 
pregnant women was estimated to be 20% 
approximately, that it was more than rural 
pregnant women with 13.7% (Figure 4). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: The prevalence of anemia among Iranians pregnant based on rural and urban 
differentiated according to WHO definition (HB less than 11 mg/dl) 
Based on random effect model, and mean point of each segment showed the estimation of percent and the length of 
each segment showed the 95% confidential interval in each study. The mark diamond showed the prevalence of each 
study. (3= Unknown) 
 
NOTE: Weights are from random effects analysis
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100.00
3.26
3.57
3.25
3.57
3.60
6.08
17.34
3.59
3.40
3.45
%
50.18
3.21
2.09
3.21
3.22
3.30
3.06
3.47
3.26
Weight
3.61
3.56
3.48
3.33
1.60
3.54
2.39
3.18
3.54
3.10
2.83
26.39
3.34
2.91
3.60
3.50
  
0-.518 .518
Sayehmiri K, et al. Iron deficiency anemia during pregnancy 
228 
 
In line with evaluating the relation 
between the prevalence of anemia among 
pregnant Iranians and the year of study, 
Meta regression model was used. Although 
the curve had downtrend, there wasn`t any 
statistically relation (P=0.318) (Figure 5). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: The Meta regression of the prevalence of Anemia among Iranians pregnant according 
to year of study 
The circles show the weight of studies. 
 
DISCUSSION 
The most prevalence anemia is IDA 
around the world.47 There are some 
reasons for IDA in pregnancy period such 
as inappropriate absorbance, chronic 
bleeding, malabsorption, haemolysis or 
combining of them.48 The severe mothers’ 
anemia has some consequences like  
pre-term birth (69.3%), post-delivery 
bleeding (26%), oligohydramnion (23.8%), 
myocardial infarction (18%), pre-eclampsia 
(17%), eclampsia (14%), placental  
abruption (3%).49 
In the present study the prevalence of 
anemia is 14.2% among pregnant Iranians 
that increases in comparison of systematic 
review done in 1993-2005, although it is 
less than WHO report for developing 
country.5 However, it should be noted that 
could be listed pregnant women studied in 
Iran, are mostly attended in health centres 
who are regularly given iron and folic acid 
supplements. In addition, national 
programs for nutritional fortification of 
flour with iron and folic acid may also 
help to reduce the overall prevalence of 
anemia. 
The prevalence of anemia among 
pregnant women in other countries, 
including Egypt (26%), Africa (52-31%), 
Central and Eastern Europe (14-40%) is 
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different.
51 The difference in the 
prevalence of anemia in various locations, 
is related to multiple factors such as the 
social and economic conditions, iron 
status, and parasitic and infectious 
diseases. 
In this study, the most prevalence is 
reported for central provinces that are in 
line with result of Safavi done in 11 
several parts of country among pregnant 
women, and lowest prevalence is reported 
for Western provinces that are in line with 
result of study done in Kermanshah by 
Pasdar, which it was evaluated on 32450 
pregnant women.26 
It seems that the differences in 
geographic region, life style and diet in 
several part of Iran are the main reason for 
wide spread reported answer based on 
geographic region in different parts of 
Iran. The prevalence of anemia in regions 
is related to some agents like social and 
economic, iron status and prevalence of 
parasitic and infectious diseases.52,53 
The prevalence among rural women is 
higher than urban and combined  
rural-urban. However, there isn`t any 
significant relation but this difference may 
be related to different life style like 
numerous pregnancies for rural women. 
However, this association was not 
statistically significant, the reason for this 
discrepancy  may be due to lifestyle, 
multiple pregnancy, do not receiving or 
getting erratic iron and folic acid 
supplements, and the small sample size 
studied in rural women pregnant, so 
prevalence of anemia in pregnant women 
in rural areas was only studied in 3 studies. 
This is in line with the result of systematic 
review; 2005.12 
There are limitations in this study, 
Including: 1) Non ability internal 
resources to search for the key words that 
can be used to combine keywords 2) Some 
medical studies were excluded because of 
low quality Particularly medical 
dissertation 3) Nonstandard framework for 
the evaluation of anemia in published 
studies. For this reason numbers of studies 
were excluded. 
 
CONCLUSION 
The prevalence of anemia among 
pregnant Iranians is less than the WHO 
report for developing country in 24 current 
years, and it increases in comparison of 
systematic review; 2005. 
One of the restrictions of this study is 
both the inability of Iranian websites for 
combined search based on mix-key words 
and the omitting some references for low 
quality like medical thesis, as well as the a 
lack of standard for evaluating the anemia 
in reported studies. 
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